Prosztatarák: vizsgálatok itt: Japán
43 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleFirst-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Where
- Tokyo
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07332455 - 3. fázisTaking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Akita, Asahikawa, Fukuoka, Fukushima, Gifu, Hirakata, Hiroshima, Kagoshima, Kashihara, Kita, Kitakyushu, Kobe, Kumamoto, Kurume, Minato, Miyazaki, Mukai-awagasaki, Nagano, Ōita, Ōmura, Saga, Sakai, Sakura, Sapporo, Shimajiri, Suita, Tōon, Yokohama
- Életkor
- 18 év and over
- People
- 1310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - No phaseTaking peopleA Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 100
- Run by
- Bayer
See details and how to joinNCT06661122 - 3. fázisTaking peopleDiagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
- Where
- Osaka, Tokyo
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- ABX advanced biochemical compounds GmbH
See details and how to joinNCT06122584 - 1. fázisTaking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Chūōku, Kashiwa, Chiba, Kōtō City, Nagoya
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Nagoya, Tokyo
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Chiba, Kyoto, Osaka
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 1. fázisTaking peopleA Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Where
- Tokyo
- Életkor
- 18 év and over
- People
- 355 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06095089 · EU 2023-504063-17-00 - 3. fázisTaking peopleA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Bunkyō City, Fukuoka, Gifu, Hidaka, Kanazawa, Kashiwa, Kobe, Matsuyama, Meguro-Ku, Sakura, Sapporo, Yokohama, Yokosuka
- Életkor
- 18 év and over
- People
- 1203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443 · EU 2025-520927-26-00 - 3. fázisTaking peopleA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Bunkyō City, Hirakata, Kanazawa, Kobe, Sagamihara, Sunto-gun, Yokohama
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946 · EU 2025-522713-29-00 - 2. fázisTaking peopleA Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Where
- Kobe
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07832292 - 3. fázisTaking peopleA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- Chiba, Fukuoka, Kanazawa, Kashiwa, Kobe, Kumamoto, Matsuyama, Osaka, Sapporo, Shinjuku-ku, Suita, Yamagata, Yokohama, Yokosuka
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00 - 3. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Chūō, Fukuoka, Gifu, Ginowan, Hamamatsu, Hiroshima, Kagoshima, Kahoku-gun, Kamakura, Kitakyushu, Kobe, Koshigaya, Kumamoto, Kurume, Kyoto, Minato, Nagano, Nagasaki, Nagoya, Niigata, Sakai, Sakura, Sapporo, Shinjuku, Tokushima, Tōon, Ube, Yufu
- Életkor
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - 1/2. fázisTaking peopleStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Where
- Kyoto
- Életkor
- 18 év and over
- People
- 205 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07288359 - 1/2. fázisTaking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Hidaka, Kagoshima, Kanagawa, Kashiwa-shi, Matsuyama, Nagaizumi-chō, Nagoya, Osakasayama-Shi, Saitama, Tokyo, Yokohama
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1. fázisTaking peopleA Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Where
- Kashiwa-shi, Kobe, Kōtoku, Sakura-shi
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07244341 · EU 2025-522512-16-00 - 1/2. fázisTaking peopleA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- Where
- Chuo Ku, Koto-ku
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07730021 · EU 2026-525938-31-00 - 1. fázisTaking peopleA Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Where
- Hirakata
- Életkor
- 18 év and over
- People
- 208 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07570979 - 1/2. fázisTaking peopleStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Where
- Chūōku, Kashiwa, Kōtoku
- Életkor
- 18 év to 130 év
- People
- 283 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07181161 · EU 2024-520026-11-00 - 2. fázisTaking peopleStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
- Where
- Chuo Ku, Kashiwa, Nagoya, Yokohama
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- Pfizer
See details and how to joinNCT04606446 - 3. fázisTaking peopleAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Chuo Ku, Fukuoka, Fukushima, Ishikawa, Kashiwa, Kobe, Kyoto, Sapporo, Yokohama
- Életkor
- 18 év to 100 év
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Akita, Eiheiji-cho,Yoshida-gun, Fukuoka, Fukushima, Gifu, Hirakata, Hiroshima, Kagoshima, Kashihara, Kita, Kitakyushu, Kobe, Kumamoto, Minato, Miyazaki, Mukai-awagasaki, Nagano, Ōita, Ōmura, Saga, Sakai, Sakura, Sapporo, Shimajiri, Suita, tabashi City, Tsu, Yokohama
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Bunkyo-ku, Fukuoka, Hidaka-shi, Kanazawa, Kita-gun, Kobe, Koshigaya-shi, Koto-ku, Matsuyama, Minato-ku, Nagoya, Osaka, Sagamihara-shi, Suita-shi, Toyama
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Chiba, Chūōku, Fukuoka, Hamamatsu, Kamakura-shi, Kanazawa, Kashiwa, Kobe, Kyoto, Sapporo, Suita-shi, Yokohama
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110